(Q46443606)

22 December 2017

title

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes (English)

1 reference

22 December 2017

1 reference

acute myeloid leukemia

1 reference

7

Razelle Kurzrock

1 reference

22 December 2017

Hagop Kantarjian

5

object named as

Hagop Kantarjian

1 reference

22 December 2017

4

Sherry Pierce

1 reference

22 December 2017

6

Maher Albitar

1 reference

Apostolia Maria Tsimberidou

22 December 2017

1

object named as

Apostolia Maria Tsimberidou

1 reference

22 December 2017

Elihu Estey

2

object named as

Elihu Estey

1 reference

22 December 2017

author name string

Sijin Wen

3

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

22 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

22 December 2017

volume

113

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

1605-1613

1 reference

22 December 2017

Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

The clinical significance of karyotype in acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Cytokine gene activity in AML cells in vivo in patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

The soluble form of interleukin-6 receptor modulates cell proliferation by acute myeloblastic leukemia blast cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Endostatin's antiangiogenic signaling network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23785

7 January 2021

Identifiers

DOI

10.1002/CNCR.23785

1 reference

22 December 2017

1 reference

22 December 2017